Company OverviewPasithea Therapeutics Corp
Pasithea Therapeutics Corp is a biotech company aiming to solve one of the world’s biggest clinical problems: brain disorders. The long-term aim is to translate research into clinic-ready drugs.
The aim of our scientific team is to develop new medications that provide better and longer-lasting results for individuals with mental health issues.
The flagship company program is focused on discovering new and effective treatments for mental health problems.
Our vision is to transform the treatment of people who suffer from psychiatric and neurological disorders.
Speaker BioCEO
Pasithea Therapeutics Corp.
Dr. Marques is a fellow at Imperial College London and a lecturer at the Institute of Psychiatry, King’s College London. Dr. Marques is also a psychiatrist at Maudsley Hospital, rated as one of the top three psychiatry centres in the world. His research focuses on topics including the mechanism of action of psychiatric medication and the unveil of novel treatment targets. Dr. Marques has received numerous prestigious awards for his research and published hundreds of scientific papers including international treatment guidelines.
